Freenome (FRNM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $11.75, -4.35% vs the prior close of $12.28.
- Volume 902.99K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FRNM slides 4.4% to $11.75, a 1-month low. Closed at $11.75, -4.35% vs the prior close of $12.28. Day range $11.63–$12.73, opened at $12.54.
FRNM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — FRNM slides 4.4% to $11.75, a 1-month low
- Closed at $11.75, -4.35% vs the prior close of $12.28. Day range $11.63–$12.73, opened at $12.54.
- Volume was 902.99K shares, 1.0x its 50-day average of 886.81K.
- Price is -19.4% vs its 50-day average ($14.58) and -6.2% vs its 200-day average ($12.53).
- 52-week range $9.95–$17.50; today's close sits at 24% of that range, 32.9% below the 52-week high.
Oct 15, 2026 — FRNM rises 0.8% to $12.28
- Closed at $12.28, +0.78% vs the prior close of $12.19. Day range $11.70–$12.65, opened at $12.08.
- Volume was 782.60K shares, 0.9x its 50-day average of 895.68K.
- Price is -15.6% vs its 50-day average ($14.56) and -2.0% vs its 200-day average ($12.53).
- 52-week range $9.95–$17.50; today's close sits at 31% of that range, 29.8% below the 52-week high.
Oct 14, 2026 — FRNM slides 3.6% to $12.19, a 1-month low, 7 down days in a row
- Closed at $12.19, -3.56% vs the prior close of $12.64. Day range $11.80–$12.72, opened at $12.50.
- Volume was 657.60K shares, 0.7x its 50-day average of 894.53K.
- Price is -16.1% vs its 50-day average ($14.53) and -2.8% vs its 200-day average ($12.54).
- 52-week range $9.95–$17.50; today's close sits at 30% of that range, 30.3% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — FRNM slides 4.4% to $12.64, a 1-month low, 6 down days in a row
- Closed at $12.64, -4.39% vs the prior close of $13.22. Day range $12.48–$13.37, opened at $13.07.
- Volume was 840.60K shares, 0.9x its 50-day average of 892.83K.
- Price is -12.9% vs its 50-day average ($14.51) and +0.8% vs its 200-day average ($12.54).
- 52-week range $9.95–$17.50; today's close sits at 36% of that range, 27.8% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — FRNM slides 16.2% to $13.22, a 1-month low on 1.8x normal volume
- Closed at $13.22, -16.22% vs the prior close of $15.78. Day range $13.07–$15.89, opened at $15.70.
- Volume was 1.62M shares, 1.8x its 50-day average of 885.62K — unusually heavy trading.
- Price is -8.7% vs its 50-day average ($14.47) and +5.4% vs its 200-day average ($12.55).
- 52-week range $9.95–$17.50; today's close sits at 43% of that range, 24.5% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — FRNM ends flat (-0.2%) to $15.78, 4 down days in a row
- Closed at $15.78, -0.19% vs the prior close of $15.81. Day range $15.48–$16.35, opened at $15.77.
- Volume was 558.80K shares, 0.6x its 50-day average of 886.08K.
- Price is +9.3% vs its 50-day average ($14.43) and +25.7% vs its 200-day average ($12.55).
- 52-week range $9.95–$17.50; today's close sits at 77% of that range, 9.8% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — FRNM dips 1.4% to $15.81, 3 down days in a row
- Closed at $15.81, -1.37% vs the prior close of $16.03. Day range $15.18–$16.20, opened at $15.85.
- Volume was 947.90K shares, 1.1x its 50-day average of 879.03K.
- Price is +10.4% vs its 50-day average ($14.32) and +26.1% vs its 200-day average ($12.54).
- 52-week range $9.95–$17.50; today's close sits at 78% of that range, 9.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — FRNM dips 2.0% to $16.03
- Closed at $16.03, -2.02% vs the prior close of $16.36. Day range $15.80–$16.62, opened at $16.20.
- Volume was 648.30K shares, 0.7x its 50-day average of 881.22K.
- Price is +12.9% vs its 50-day average ($14.20) and +28.0% vs its 200-day average ($12.52).
- 52-week range $9.95–$17.50; today's close sits at 81% of that range, 8.4% below the 52-week high.
Oct 6, 2026 — FRNM dips 2.8% to $16.36
- Closed at $16.36, -2.79% vs the prior close of $16.83. Day range $16.11–$17.30, opened at $16.82.
- Volume was 712.30K shares, 0.8x its 50-day average of 895.95K.
- Price is +16.1% vs its 50-day average ($14.10) and +30.8% vs its 200-day average ($12.50).
- 52-week range $9.95–$17.50; today's close sits at 85% of that range, 6.5% below the 52-week high.
Oct 5, 2026 — FRNM jumps 3.1% to $16.83
- Closed at $16.83, +3.13% vs the prior close of $16.32. Day range $15.90–$17.12, opened at $16.28.
- Volume was 772.70K shares, 0.9x its 50-day average of 892.00K.
- Price is +20.2% vs its 50-day average ($14.00) and +34.8% vs its 200-day average ($12.48).
- 52-week range $9.95–$17.50; today's close sits at 91% of that range, 3.8% below the 52-week high.
Oct 2, 2026 — FRNM jumps 4.3% to $16.32
- Closed at $16.32, +4.35% vs the prior close of $15.64. Day range $15.48–$16.35, opened at $15.75.
- Volume was 813.60K shares, 0.9x its 50-day average of 891.00K.
- Price is +17.5% vs its 50-day average ($13.88) and +31.0% vs its 200-day average ($12.46).
- 52-week range $9.95–$17.50; today's close sits at 84% of that range, 6.7% below the 52-week high.
FRNM latest news & SEC filings
Every SEC filing by or about FRNM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 27, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 27, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 18, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 2.01 — Completed an acquisition or sale of assets.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · Form POS AM — POS AM filing
POS AM filing
Things to know before you trade FRNM
- How much it moves: over the last 20 sessions the average daily move was 2.92% (largest 16.2%).
- Liquidity: about 689.60K shares (≈$8.10M) trade per day on average.
- 52-week position: $11.75 vs a range of $9.95–$17.50 (24% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Jul 27, 2026; 8-K Jul 24, 2026; 8-K Jul 15, 2026.
- Share count: 8.91M shares outstanding (Mar 10, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
FRNM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.54 | 12.73 | 11.63 | 11.75 | 902.99K |
| Oct 15, 2026 | 12.08 | 12.65 | 11.70 | 12.28 | 782.60K |
| Oct 14, 2026 | 12.50 | 12.72 | 11.80 | 12.19 | 657.60K |
| Oct 13, 2026 | 13.07 | 13.37 | 12.48 | 12.64 | 840.60K |
| Oct 12, 2026 | 15.70 | 15.89 | 13.07 | 13.22 | 1.62M |
| Oct 9, 2026 | 15.77 | 16.35 | 15.48 | 15.78 | 558.80K |
| Oct 8, 2026 | 15.85 | 16.20 | 15.18 | 15.81 | 947.90K |
| Oct 7, 2026 | 16.20 | 16.62 | 15.80 | 16.03 | 648.30K |
| Oct 6, 2026 | 16.82 | 17.30 | 16.11 | 16.36 | 712.30K |
| Oct 5, 2026 | 16.28 | 17.12 | 15.90 | 16.83 | 772.70K |
| Oct 2, 2026 | 15.75 | 16.35 | 15.48 | 16.32 | 813.60K |
| Oct 1, 2026 | 15.78 | 16.40 | 15.60 | 15.64 | 586.00K |
| Sep 30, 2026 | 15.88 | 16.26 | 15.58 | 15.75 | 518.50K |
| Sep 29, 2026 | 16.22 | 16.54 | 15.41 | 15.92 | 508.20K |
| Sep 28, 2026 | 15.99 | 16.42 | 15.66 | 16.19 | 255.90K |
| Sep 25, 2026 | 15.95 | 16.23 | 15.37 | 15.99 | 418.80K |
| Sep 24, 2026 | 15.57 | 16.17 | 15.28 | 16.01 | 507.80K |
| Sep 23, 2026 | 16.44 | 16.44 | 15.39 | 15.70 | 578.50K |
| Sep 22, 2026 | 16.65 | 16.86 | 16.00 | 16.45 | 568.00K |
| Sep 21, 2026 | 17.19 | 17.50 | 16.60 | 16.60 | 588.20K |
About Freenome
Freenome (FRNM) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in BRISBANE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2017526.
FRNM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ann Catherine Costello | Director | Jul 27, 2026 |
| Aaron Matthew Elliott | Chief Executive Officer | Sep 4, 2026 |
| Peter Kolchinsky | Director | Jul 22, 2026 |
| Carole Nuechterlein | Director | Jul 27, 2026 |
| Deepika Pakianathan | Director | Jul 27, 2026 |
| Capital Management, L.P. Ra | Director | Jul 22, 2026 |
| Capital Healthcare Fund Lp Ra | Director | Jul 22, 2026 |
| Capital Nexus Fund Ii, L.P. Ra | Director | Jul 22, 2026 |
| Capital Nexus Fund Iii, L.P. Ra | Director | Jul 22, 2026 |
| Capital Nexus Fund, L.P. Ra | Director | Jul 22, 2026 |
| Randal W. Scott | Director | Jul 27, 2026 |
| Rajeev M. Shah | Director | Jul 22, 2026 |
| Oort Douglas M Van | Director | Jul 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Aaron Matthew Elliott | Chief Executive Officer | Sep 4, 2026 |
| Riley Charles Ennis | Chief Product Officer | Jul 27, 2026 |
| Linh H. Le | Chief Financial Officer | Jul 27, 2026 |
| Cheng-Ho Jimmy Lin | Chief Scientific Officer | Jul 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
FRNM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $837.47K | — | $-864.65K |
Latest balance sheet: total assets $85.83M, total liabilities $7.08M, cash $— (as of Jun 30, 2026).
FRNM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on FRNM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.